GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug shows promise against deadly brain tumor
Disease control Recruiting nowThis study tests whether adding metformin, a common diabetes drug, to standard radiation and chemotherapy can slow the growth of a specific type of glioblastoma brain tumor. It includes about 64 newly diagnosed patients whose tumors have a unique energy profile. The goal is to se…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: Hopital Foch • Aim: Disease control
Last updated May 16, 2026 22:30 UTC
-
New combo therapy takes on deadly brain cancer
Disease control Recruiting nowThis study tests a drug called WP1066 combined with radiation therapy for people with a newly diagnosed aggressive brain cancer called glioblastoma. The drug targets a protein that helps the tumor grow and hide from the immune system, while radiation kills cancer cells. The goal …
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 16, 2026 22:27 UTC
-
New hope for aggressive brain tumors: drug combo shows promise before surgery
Disease control Recruiting nowThis study tests two drugs, GI-102 and pembrolizumab, given before surgery to people whose aggressive brain cancer (glioblastoma) has returned. The goal is to see if these drugs can shrink the tumor and help the immune system fight the cancer. About 36 adults will take part, and …
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Blood sugar tracker may extend life in brain cancer patients
Disease control Recruiting nowThis study tests whether a continuous glucose monitor (CGM) can help people with glioblastoma manage their blood sugar and possibly live longer. High blood sugar during treatment is linked to worse outcomes, and steroids often cause it. The CGM device tracks glucose in real time,…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New pill shows promise for Hard-to-Treat brain cancers
Disease control Recruiting nowThis study tests an experimental oral drug called NEO212 in people with certain brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control the disease. About 134 adults will take part across t…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Promising new combo may extend life in aggressive brain cancer
Disease control Recruiting nowThis study tests whether adding another chemotherapy drug (lomustine) to the standard treatment can help people with a specific type of glioblastoma, a fast-growing brain cancer, live longer. About 200 adults aged 18-70 with newly diagnosed, MGMT-methylated glioblastoma will be r…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE3 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Targeted radiation shows promise for aggressive brain tumors in early trial
Disease control Recruiting nowThis study tests a new radioactive drug, 177Lu-PSMA-617, to see if it is safe for people with a fast-growing type of brain tumor called IDH wild type glioma. The drug targets a protein (PSMA) found on these tumor cells and delivers radiation directly to them. About 20 adults whos…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
New brain scan study aims to end guesswork in glioblastoma treatment
Knowledge-focused Recruiting nowThis study looks at whether advanced imaging methods can give more accurate information about tumor activity in people with a newly diagnosed type of brain cancer called glioblastoma. Standard MRI scans can be confusing because changes after treatment may look like tumor growth b…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated May 16, 2026 22:32 UTC